Today: 21 May 2026
Shell stock slips on oil slump; Vietnam LNG win and Angola deal set up next catalysts
7 January 2026
2 mins read

Shell stock slips on oil slump; Vietnam LNG win and Angola deal set up next catalysts

NEW YORK, Jan 7, 2026, 03:29 EST — Market closed

  • Shell’s U.S.-listed shares fell 2.8% on Tuesday to $72.90.
  • Vietnam’s Petrovietnam Gas picked Shell for its first term LNG tender, with deliveries from 2027 to 2031.
  • Investors are weighing buybacks and new upstream spending against softer crude prices.

Shell Plc’s U.S.-listed shares (SHEL) fell 2.8% on Tuesday to $72.90. After U.S. markets shut, Vietnam’s Petrovietnam Gas said it awarded Shell its first term tender for liquefied natural gas (LNG), the super-chilled fuel shipped by tanker, with supplies running from 2027 to 2031. The stock’s $72.85 low left the $73 area in focus ahead of the next session.

The Vietnam award gives Shell a foothold in a market shifting away from one-off spot purchases and toward longer contracts. For investors, it is another data point in a bigger question: how hard Big Oil can lean on growth while defending shareholder payouts when crude prices look capped.

Oil extended losses on Wednesday after U.S. President Donald Trump said Washington struck a deal to import $2 billion worth of Venezuelan crude, which analysts said would add supply. Brent was down 1.3% at $59.89 a barrel and U.S. crude fell 1.7% to $56.13 by 0550 GMT. “Venezuela’s oil exports to the United States have first and foremost disrupted the U.S. market, which will also deepen the global oversupply,” Haitong Futures analyst Yang An said; Morgan Stanley estimated a surplus of up to 3 million barrels per day in the first half of 2026. Reuters

Petrovietnam Gas said Shell will deliver LNG on a delivered ex-ship basis, meaning Shell covers shipping to the buyer’s terminal. The cargoes are set for the Thi Vai import terminal near Ho Chi Minh City, which began taking LNG in 2023 and supplies gas-fired power plants that started commercial operations in mid-December. Vietnam imported about 0.5 million tons of LNG in 2025 — all bought on the spot market — Kpler data showed.

Shell also said on Tuesday it signed a farm-in agreement — buying into exploration licences — with Chevron’s Cabinda Gulf Oil to take a 35% stake in Angola’s ultra-deepwater Blocks 49 and 50. The deal has government approval and is pending final legal steps, while Chevron said it remains subject to regulatory approval. “New exploration, such as in Angola, is important to sustaining production into the 2030s,” Shell said, adding it aims to grow gas output 1% through 2030 and keep oil production steady. Reuters

On the capital-returns front, Shell bought 735,166 shares in London and 737,132 shares in Amsterdam on Jan. 6 for cancellation, the company said in a buyback update. The repurchases are part of a $3.5 billion programme announced on Oct. 30 that runs through Jan. 30, with Merrill Lynch International making trading decisions independently. Shell has said it intends to finish the programme before it reports fourth-quarter results.

Brent settled at $60.70 a barrel on Tuesday, keeping pressure on energy earnings expectations. “Oil supply will be sufficient in 2026, with or without an increase in production from the OPEC member,” said Tamas Varga, an analyst at PVM Oil. For Shell, a weaker oil strip can sharpen scrutiny of cash returns and spending discipline. Reuters

But the new deals will take time to show up in cash flow, and the Angola entry still needs final legal and regulatory steps. If crude stays near $60 or sinks further, traders may focus less on expansion and more on how much Shell can keep sending back through dividends and buybacks.

Stock Market Today

  • Installed Building Products Stock: Revenue and Earnings Growth Slow Amid Market Underperformance
    May 20, 2026, 10:53 PM EDT. Installed Building Products' stock fell 15.9% to $208.38 over six months, underperforming the S&P 500's 13.3% gain. The slowdown in revenue growth to 2.4% annualized over two years contrasts with a 5-year trend of 11.7%. Earnings per share growth also lagged at 2.6%, reflecting persistent but subdued profitability. The stock trades at a forward price-to-earnings ratio of 20.8, indicating a fair valuation but limited near-term optimism. Analysts highlight a cautious outlook due to softer quarterly results and unproven impact from new offerings, suggesting investors may find better opportunities elsewhere.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says
Previous Story

Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings
Next Story

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

Go toTop